- Home
- ALTG vs NMRA Comparison
ALTG vs NMRA Comparison
Compare ALTG & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- NMRA
- Stock Information
- Founded
- ALTG 1984
- NMRA 2019
- Country
- ALTG United States
- NMRA United States
- Employees
- ALTG N/A
- NMRA N/A
- Industry
- ALTG Industrial Machinery/Components
- NMRA
- Sector
- ALTG Industrials
- NMRA
- Exchange
- ALTG Nasdaq
- NMRA Nasdaq
- Market Cap
- ALTG 227.2M
- NMRA 268.5M
- IPO Year
- ALTG N/A
- NMRA 2023
- Fundamental
- Price
- ALTG $6.83
- NMRA $1.86
- Analyst Decision
- ALTG Hold
- NMRA Hold
- Analyst Count
- ALTG 3
- NMRA 8
- Target Price
- ALTG $11.67
- NMRA $5.83
- AVG Volume (30 Days)
- ALTG 223.2K
- NMRA 489.7K
- Earning Date
- ALTG 11-11-2025
- NMRA 11-11-2025
- Dividend Yield
- ALTG 3.39%
- NMRA N/A
- EPS Growth
- ALTG N/A
- NMRA N/A
- EPS
- ALTG N/A
- NMRA N/A
- Revenue
- ALTG $1,851,100,000.00
- NMRA N/A
- Revenue This Year
- ALTG $1.30
- NMRA N/A
- Revenue Next Year
- ALTG $3.26
- NMRA N/A
- P/E Ratio
- ALTG N/A
- NMRA N/A
- Revenue Growth
- ALTG N/A
- NMRA N/A
- 52 Week Low
- ALTG $3.54
- NMRA $0.61
- 52 Week High
- ALTG $8.99
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- ALTG 39.29
- NMRA 58.78
- Support Level
- ALTG $6.40
- NMRA $1.70
- Resistance Level
- ALTG $7.14
- NMRA $1.93
- Average True Range (ATR)
- ALTG 0.33
- NMRA 0.13
- MACD
- ALTG -0.07
- NMRA 0.01
- Stochastic Oscillator
- ALTG 25.59
- NMRA 82.05
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.